Inpharmatis is excited to announce of the opening of yet another Inpharmatis Company in Uzbekistan (which is an addition of a separate legal entity within a Group of Companies to the current Representative Office of the Head Office in Latvia). It is designed to provide better support global pharmaceutical companies aiming to register and launch their products in Uzbekistan. 

Inpharmatis continues to provide a comprehensive range of services for regulatory affairs, pharmacovigilance, quality management, GMP, GDP, GVP, GxP audits, and electronic solutions. 

Additionally, Inpharmatis offers the ability to pay local state fees directly in the local currency (Uzbekistani som) – that has now become the only available option for state fees payment, streamlining the registration process and simplifying interactions with regulatory authorities. 

To further strengthen local expertise, Inpharmatis is actively expanding its team of regional specialists fluent in the Uzbek language. We are bringing on board experts with in-depth knowledge of the local regulatory environment, ensuring that our Clients receive accurate, timely, and expert guidance throughout the registration and approval process in Uzbekistan. 

This expansion aligns with Inpharmatis’ mission to deliver comprehensive solutions to pharmaceutical companies seeking to access Central Asian markets — including Uzbekistan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Mongolia — as well as the broader ex-CIS region, minimising risks while maximising opportunities. 

For more information on how Inpharmatis can support your medicines registration processes in Uzbekistan, please contact us - info@inpharmatis.com.